CIBC World Market’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-5,262
Closed -$248K 1366
2022
Q3
$248K Sell
5,262
-1,700
-24% -$110K ﹤0.01% 1069
2022
Q2
$499K Sell
6,962
-15,171
-69% -$1.11M ﹤0.01% 881
2022
Q1
$1.79M Buy
22,133
+15,091
+214% +$1.28M 0.01% 611
2021
Q4
$723K Buy
7,042
+100
+1% +$9.6K ﹤0.01% 870
2021
Q3
$607K Buy
+6,942
New +$628K ﹤0.01% 915
2020
Q2
Sell
-8,232
Closed -$325K 1171
2020
Q1
$325K Buy
+8,232
New +$481K ﹤0.01% 802
2018
Q3
Sell
-4,960
Closed -$233K 1247
2018
Q2
$233K Sell
4,960
-1,540
-24% -$63.7K ﹤0.01% 1034
2018
Q1
$231K Hold
6,500
﹤0.01% 1057
2017
Q4
$283K Buy
+6,500
New +$304K ﹤0.01% 676

Other funds holding SYNH

CIBC World Market's SYNH Position: Q4 2022 in Review

CIBC World Market sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2022, closing a stake of 5,262 shares — an estimated $248K sold.

CIBC World Market first reported a position in SYNH in Q4 2017 and held it in 9 quarters. The position peaked at $1.79M in Q1 2022. 307 funds tracked by Wall St. Rank hold SYNH as of Q4 2022.

  • CIBC World Market reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • CIBC World Market sold 5,262 Syneos Health, Inc. Class A Common Stock shares in Q4 2022, an estimated $248K.
  • CIBC World Market first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2017 and held it in 9 quarters.
  • CIBC World Market's Syneos Health, Inc. Class A Common Stock position peaked at $1.79M in Q1 2022.
  • 307 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2022.

Based on CIBC World Market's 13F filing for Q4 2022, filed 13 Feb 2023.